$45.08
-0.81 (-1.77%)
Performance
1D
—
1W
-0.57%
1M
+8.76%
3M
-8.74%
6M
+27.09%
1Y
+42.30%
YTD
+59.52%
Open$45.89
Previous Close$45.89
Day High$46.56
Day Low$44.65
52W High$55.67
52W Low$27.00
Volume—
Avg Volume1.88M
Market Cap7.61B
P/E Ratio115.11
EPS$0.38
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$43.86
Above
SMA 200
$40.68
Above
RSI (14)
81
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
26 analysts
Price Target
+180.4% upside
Current
$45.08
$45.08
Target
$126.40
$126.40
$90.34
$126.40 avg
$146.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.47B | 1.34B | 1.89B |
| Net Income | 240.41M | 196.88M | 267.01M |
| Profit Margin | 16.4% | 15.6% | 14.1% |
| EBITDA | 258.22M | 223.21M | 438.15M |
| Free Cash Flow | — | — | 233.31M |
| Rev Growth | +9.9% | +9.9% | +6.3% |
| Debt/Equity | — | — | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |